Viewpoint: Are the U.S. and Europe headed towards a repudiation of agricultural biotechnology red tape?

Screenshot 2026-07-22 at 1.38.55 PM

2026 may well be remembered as the year global agriculture began to untangle itself from decades of precautionary red tape. Earlier this year, the agricultural biotechnology landscape shifted in two places that have long defined opposite poles of the regulatory debate: the European Union, historically the home of exceedingly precautionary biotech rules, and the United States, a pro-innovation leader now eyeing a massive regulatory overhaul.

The EU Parliament recently approved a landmark framework for regulating New Genomic Techniques (NGTs). Many plants developed with CRISPR or other precise gene-editing techniques will now be treated more like conventional crops by regulators than transgenics, commonly referred to as “GMOs.” Meanwhile, the US Department of Agriculture is weighing a clean break from its legacy Part 340 biotechnology rules, in place since the late 1980s.

Together, these moves mark a broader retreat from process-based regulation toward more risk-based and technology-agnostic frameworks. Product-based regulations ask what a product does, what risks it plausibly poses, and whether regulation will actually improve safety—rather than focusing on the technology used in development. This is about more than administrative streamlining; it’s the key to a new wave of agricultural innovation.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

While the EU’s NGT reforms and the US’s potential overhaul are steps in the right direction, true modernization demands that all genetically engineered products—gene-edited and transgenic alike—be treated the same as conventionally bred crops. Continuing to differentiate between these categories as a proxy for risk conflicts with the scientific consensus that gene-edited and transgenic crops don’t pose new risks compared to conventional breeding, often making changes to a plant’s DNA with greater speed and accuracy and fewer unintended changes. Only by aligning regulations with established science will we unlock the benefits of biotechnology innovation in agriculture.

Emily Bass is Associate Director of Federal Policy, Food and Agriculture at Breakthrough Institute. Follow Emily on X @EmilyJane_Bass

A version of this article was originally posted at The Ecomodernist and has been reposted here with permission. Any reposting should credit the original author and provide links to both the GLP and the original article. Find Breakthrough Institute on X @TheBTI

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Supplement Rain Wellness Illustration
Viewpoint: Bedeviled by “toxic inflammation”? How wellness grifters turn this scientific gray zone into a supplement jackpot
Teal Hexagon Technology Icons
4 key ways the Blue Wave will upend science policy
Aerial Sprayer Over Gradient Fields
Farming, food, and chemicals: Post-midterms, the MAHA alliance between Democrats and MAGA Republicans is bruised but not cowed. What comes next?
Wave Crest Over Red Cross
Viewpoint: Here are the election-inspired Trump administration healthcare policy reversals expected in the coming months
Confident Doctor in Clinical Setting
More than 80% of ‘pro-science’ candidates were swept into office. Will they have a policy impact?
Stacked Protest Signs on Concrete Ledge
Voters hate AI data centers, yet they are crucial to establishing a critical technology. So what’s next?
Protect-Womens-Sports-at-the-Capitol
Blue, purple and red states passed or reaffirmed bans on trans females competing in women’s sports
Microscopic IVF Egg Injection
With technical barriers to human embryo editing falling, ethical concerns escalate
Democratic Donkey Plowing at Sunset
Viewpoint: Democratic tsunami: As the red tide recedes, here are the most likely shifts in food and agricultural policy
Screenshot-2026-11-05-at-1.20.54-PM
$7.35 billion PFAS settlement: 3M to pay people who blame health problems on ‘forever chemicals’ phased out of firefighting foam for more than 20 years
Bayer Crop Circle in Golden Wheat
Making fertilizer from thin air: Bayer’s gene-editing innovation could dramatically cut chemical fertilizer use in growing food
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.